NCT02101866View on ClinicalTrials.gov

A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Vapendavir 300 mg tablet

tablet - single dose

DRUG

Vapendavir 132 mg capsules

2 capsules - single dose

Trial Locations (1)

55101

Investigative Site, Saint Paul

Sponsors
All Listed Sponsors
lead

Biota Pharmaceuticals, Inc.

INDUSTRY